Tetra-probe, 24-hour pH monitoring for laryngopharyngeal reflux: A technique for simultaneous study of hypopharynx, oesophagus and stomach

Journal of Laryngology and Otology

Volumn 123, Issue S31, 2009, Pages 117-122

  Sato, K ^a   Umeno, H ^a   Chitose, S ^a   Nakashima, T ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

GERD; Laryngopharyngeal Reflux Disease; pH Monitoring; Tetra probe

Indexed keywords

AGED; ARTICLE; ESOPHAGEAL PH MONITORING; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; HYPOPHARYNX; INSTRUMENTATION; LARYNX DISORDER; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PH; PHARYNX DISEASE; PREDICTION AND FORECASTING; REFERENCE VALUE; REPRODUCIBILITY; STOMACH PH;

AGED; AGED, 80 AND OVER; ESOPHAGEAL PH MONITORING; FEMALE; GASTRIC ACIDITY DETERMINATION; GASTROESOPHAGEAL REFLUX; HUMANS; HYDROGEN-ION CONCENTRATION; HYPOPHARYNX; LARYNGEAL DISEASES; MALE; MIDDLE AGED; PHARYNGEAL DISEASES; PREDICTIVE VALUE OF TESTS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS;

EID: 74049124496     PISSN: 00222151     EISSN: 17485460     Source Type: Journal    
DOI: 10.1017/S0022215109005222     Document Type: Article

References (14)

1. Koufman JA. Laryngopharyngeal reflux 2002: a new paradigm of airway disease. ENT J 2002; 81(suppl 2):117–122
2. Koufman JA, Aviv JE, Casiano RR, Shaw GY. Laryngopharyngeal reflux: position statement of the Committee on Speech, Voice, and Swallowing Disorders of the American Academy of Otolaryngology-Head and Neck Surgery. Otolaryngol Head Neck Surg 2002; 127: 32–5
3. Postma GN. Ambulatory pH monitoring methodology. Ann Otol Rhinol Laryngol 2000; 109(suppl 184):10–14
4. Postma GN, Belafsky PC, Aviv JE, Koufman JA: Laryngopharyngeal reflux testing. ENT J 2002; 81(suppl 2):14–18
5. Sato K. Tetra-probe 24-hour monitoring for laryngopharyngeal reflux diseases. J Jpn Bronchoesophagol Soc 2004; 55: 9–15
6. Feussner H, Petri A, Walker S, Bollschweiner E, Siewert JR. The modified AFP score: an attempt to make the results of anti-reflux surgery comparable. Br J Surg 1991; 78: 942–6
7. Smit CF, Tan J, Devriese PP, Mathus-Vliegen LMH, Brandsen M, Schouwenburg PF. Ambulatory pH measurements at the upper esophageal sphincter. Laryngoscope 1998; 108: 299–302
8. Bough ID Jr, Sataloff RT, Castell DO, Hills JR, Gideon RM, Spiegel JR. Gastroesophageal reflux laryngitis resistant to omeprazole therapy. J Voice 1995; 9: 205–11
9. Sato K, Nakashima T. Laryngopharyngeal reflux diseases resistant to antacid therapy. J Jpn Bronchoesophagol Soc 2004; 55: 414–22
10. Sato K. Laryngopharyngeal reflux disease with nocturnal gastric acid breakthrough while on proton pump inhibitor therapy. Eur Arch Otolaryngol 2006; 263: 1121–6
11. Peghini PL, Katz PO, Bracy NA, Castell DO. Nocturnal recovery of gastric acid secretion with twice-daily dosing of proton pump inhibitors. Am J Gastroenterol 1998; 93: 763–7
12. Ishizaki T, Horai Y. Review article. Cytochrome P450 and the metabolism of proton pump inhibitors – emphasis on rabeprazole. Aliment Pharmacol Ther 1999; 13(suppl 3):27–36
13. Adachi K, Katsube T, Kawamura A, Takashima T, Yuki M, Amano K, Ishihara S, Fukuda R, Watanabe M, Kinoshita Y. YP2C19 genotype status and intragastric pH during dosing with lansoplazole or rabeprazole. Aliment Pharmacol Ther 2000; 14: 1259–66
14. Axford SE, Sharp N, Ross PE, Pearson JP, Dettmar PW, Panetti M, et al Cell biology of laryngeal epithelial defences in health and disease. Preliminary studies. Ann Otol Rhinol Laryngol 2001; 110: 1099–108, 11768697